Holen Sie sich die Stockscreener-App
27.06
1.89%
-0.52
Vorhandelsmarkt:
27.27
0.21
+0.78%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt PHG?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$27.58
Offen:
$27.06
24-Stunden-Volumen:
590.35K
Relative Volume:
0.57
Marktkapitalisierung:
$26.06B
Einnahmen:
$19.49B
Nettoeinkommen (Verlust:
$-909.25M
KGV:
-33.37
EPS:
-0.8109
Netto-Cashflow:
$966.68M
1W Leistung:
-2.70%
1M Leistung:
+2.27%
6M Leistung:
+3.96%
1J Leistung:
-10.31%
1-Tages-Spanne:
$26.94
$27.32
1-Wochen-Bereich:
$26.94
$27.75
52-Wochen-Spanne:
$21.48
$32.91
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Firmenname
Koninklijke Philips N V Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PHG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHG
Koninklijke Philips N V Adr
|
27.06 | 26.22B | 19.49B | -909.25M | 966.68M | -0.8109 |
|
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-25 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2025-02-20 | Hochstufung | UBS | Neutral → Buy |
| 2024-10-29 | Hochstufung | Jefferies | Underperform → Hold |
| 2024-05-13 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-05-07 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-04-30 | Hochstufung | UBS | Sell → Neutral |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-01-17 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-14 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-09-12 | Hochstufung | Societe Generale | Hold → Buy |
| 2022-09-06 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-06-16 | Herabstufung | UBS | Neutral → Sell |
| 2022-01-20 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-14 | Hochstufung | HSBC Securities | Hold → Buy |
| 2022-01-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-08 | Eingeleitet | Jefferies | Buy |
| 2021-07-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-06-21 | Herabstufung | HSBC Securities | Buy → Hold |
| 2021-03-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-07-28 | Eingeleitet | Societe Generale | Buy |
| 2019-07-30 | Eingeleitet | Citigroup | Buy |
| 2018-02-12 | Hochstufung | Berenberg | Hold → Buy |
| 2017-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-10-16 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2017-06-21 | Herabstufung | Natixis Bleichroeder | Buy → Neutral |
| 2017-04-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2016-12-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-23 | Eingeleitet | Citigroup | Buy |
| 2016-05-11 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2016-03-01 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2016-02-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2015-11-27 | Eingeleitet | ING Group | Hold |
| 2015-09-08 | Eingeleitet | Credit Suisse | Outperform |
| 2015-08-27 | Hochstufung | Nomura | Neutral → Buy |
| 2015-07-28 | Hochstufung | Societe Generale | Hold → Buy |
| 2011-01-25 | Herabstufung | HSBC Securities | Overweight → Neutral |
| 2009-12-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2009-10-16 | Hochstufung | HSBC Securities | Neutral → Overweight |
| 2009-05-08 | Herabstufung | UBS | Buy → Neutral |
Alle ansehen
Koninklijke Philips N V Adr Aktie (PHG) Neueste Nachrichten
Defibrillators Industry Analysis and Growth Forecast to 2030: ICDs Dominated Global Market Share in 2024 - GlobeNewswire Inc.
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
10 Undervalued Stocks That Crushed Q1 Earnings - Morningstar
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Sony Group Corp. ADR rises Wednesday, still underperforms market - MarketWatch
Sony Group Corp. ADR outperforms market despite losses on the day - MarketWatch
Sony Group Corp. ADR rises Thursday, outperforms market - MarketWatch
CBRE Group Inc (CBRE) Stock: A Closer Look at the Market Potential - News Heater
Sony Group Corp. ADR outperforms competitors despite losses on the day - MarketWatch
Taiwan Air Treatment Systems Industry Report: From AIoT to Wearables - GlobeNewswire Inc.
Sony Group Corp. ADR rises Friday, outperforms market - MarketWatch
Selling Your Koninklijke Philips N.V. ADR (PHG) Stock? Here’s What You Need To Know - Stocks Register
Data-Based Insights About Koninklijke Philips N.V. ADR (PHG) - Stocks Register
Sony Group Corp. ADR outperforms market on strong trading day - MarketWatch
Sony Group Corp. ADR underperforms Friday when compared to competitors - MarketWatch
Sony Group Corp. ADR falls Tuesday, underperforms market - MarketWatch
Weekly Upgrades and Downgrades - InvestorPlace
Sony Group Corp. ADR falls Monday, underperforms market - MarketWatch
Sony Group Corp. ADR outperforms competitors on strong trading day - MarketWatch
Sony Group Corp. ADR underperforms Thursday when compared to competitors - MarketWatch
Philips Avent Enters the Smart Parenting Category with the launch of its most advanced baby monitor: the Premium Connected Baby Monitor - Ariva
New 4-Star Stocks - Morningstar
Sony Group Corp. ADR rises Friday, still underperforms market - MarketWatch
GE HealthCare: Initiating Coverage With Wide Moat, Shares Look Attractive - Morningstar
Healthcare Sector - Morningstar
Philips Stock Books Record Gain After U.S. Ventilator Settlement - WSJ
Philips creates 'clear path forward' with FDA over Respironics probe - Sharecast.com
Finanzdaten der Koninklijke Philips N V Adr-Aktie (PHG)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.48%
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):